Caffeine Dose Response Study To Support Category I Status Proposed By BMS
This article was originally published in The Tan Sheet
Executive Summary
A placebo-controlled, dose-response trial comparing acetaminophen to combinations of caffeine with aspirin and acetaminophen has been proposed by Bristol-Myers Squibb.
You may also be interested in...
Bayer Looks To Quick Release Crystals To Shine Light On Aspirin Brand
As private label OTCs threaten brand name stalwarts in the deepening economic recession, Bayer hopes to galvanize its iconic aspirin line with a powdered delivery format in single-dose pouches
Bayer Looks To Quick Release Crystals To Shine Light On Aspirin Brand
As private label OTCs threaten brand name stalwarts in the deepening economic recession, Bayer hopes to galvanize its iconic aspirin line with a powdered delivery format in single-dose pouches
Bayer Looks To Quick Release Crystals To Shine Light On Aspirin Brand
As private label OTCs threaten brand name stalwarts in the deepening economic recession, Bayer hopes to galvanize its iconic aspirin line with a powdered delivery format in single-dose pouches